With 38 crore people infected India may have reached herd immunity

▴ With 38 crore people infected India may have reached herd immunity
The study strongly advocates the fact that a timely lockdown may have reduced the fatality of coronavirus cases in India

A study has claimed that India may have reached herd immunity with about 380 million or 38 crore people already infected.

The detailed study published in the Indian Journal of Medical Research (IJMR) claims to have used susceptible-asymptomatic-infected-recovered (SAIR) model to assess the impact of the lockdown and make predictions on its future course.

“The SAIR model has helped us understand the disease better. If the model is correct, we may have reached herd immunity with about 38 crore people already infected. However, personal protective measures remain crucial,” the authors Manindra Agrawal, Madhuri Kanitkar and M Vidyasagar were quoted in the study as saying.

The study strongly advocates the fact that a timely lockdown may have reduced the fatality of coronavirus cases in India. It also claims that without a lockdown intervention led by the Indian government in the month of March, Covid-19 infections would have peaked by June 2020.

“If there was no lockdown, the number of active infections would have peaked at close to 14.7 million (1.4 crores), resulted in more than 2.6 million (26 lakh) deaths, and the peak would have arrived by June 2020. The number of deaths with the current trends may be less than 0.2 million (2 lakhs),” notes the study.

Method and modelling:

The standard mathematical models could not explain the role of asymptomatic cases in the unfolding of the pandemic, the study noted. A new model was used which was developed on lines of SAIR.

“There is a paucity of data on the behaviour of the virus among the Indian population. Limited testing capability in India at the time of onset of the pandemic, non-availability of standardized tests for serosurveillance and non-availability of data on asymptomatic cases were other limitations. In the current Covid-19 pandemic, a large fraction of the population showed little or no symptoms,” said the study.

Four parameters were used, namely:

Measures the likelihood of the susceptible people getting infected, and denotes recovery rate of patients. The ratio is denoted by R0 (basic reproduction number).

Pandemic progression in India:

The actual data suggested a peak in coronavirus cases in India on September 17, 2020. The model overestimates the actual growth by around 1.5 per cent and the peak arrives four days later. Cumulative deaths are predicted to be around 0.2 million.

The and values for the last phase imply R0 value around 1.39, and the herd immunity for this value of R0 at around 28 per cent of the population in A, I and R categories.

According to the study, around 3.9 million (39 lakh) population was infected or with antibodies at the peak. On September 17, the numbers in I and RI categories were around 5.2 million (52 lakh). Using the 1/ value (=67) of phase 6, the model predicts the total population with infection or antibodies to be around 3.5 million (35 lakh).

Story Source: www.indiatoday.com 

Tags : #IndianJournalofMedicalResearch #HerdImmunity #COVIDAntibody #LatestCOVIDNews23rdOct #Lockdown #FatalityRate #COVID19Pandemic

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

10 PCOS Warning Signs That Need Your AttentionDecember 27, 2024
Experts Dub 2024 as the Year of Technologies and Innovations in Healthcare; Stress on further Integration of Technologies December 27, 2024
Aakash Healthcare Partners with Japan for Groundbreaking Surgical Intervention: A Global Collaboration to Revolutionize Cardiovascular CareDecember 26, 2024
Traditional Medicine Goes Global: How Ayush 2024 Reimagined WellnessDecember 26, 2024
Aster Guardians Global Nursing Award 2025 worth INR 2 Crore now open for nominations worldwide December 26, 2024
Holiday Season Round the Corner? 6 Daily Habits That Could Be The Reason Behind Your Fatty LiverDecember 26, 2024
Healing the Nation: Doctors as Architects of a Healthier FutureDecember 26, 2024
Brewing Health Benefits: Can Coffee and Tea Help Fight Head and Neck Cancers?December 26, 2024
Seven-Year-Old Fights Back Against Rare Autoimmune DiseaseDecember 26, 2024
Olympus Named to Dow Jones Sustainability World Index for the Fourth Consecutive YearDecember 26, 2024
American Oncology Institute (AOI) in Nagpur Restores Mobility with KyphoplastyDecember 26, 2024
Sanjeevani Healthcare & Wellness Expo 2024: A Dynamic Platform for Global Healthcare CollaborationDecember 23, 2024
Ranitidine: Saviour or Suspect? The Truth Behind the Stomach Acid RemedyDecember 23, 2024
From One-Size-Fits-All to Precision Medicine: The New Hope for Rare Bone Cancer PatientsDecember 23, 2024
World Meditation Day: India’s Gift of Peace to a Chaotic WorldDecember 23, 2024
Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and TreatmentDecember 23, 2024
Black Angels remind us of centuries of injustices plaguing the TB responseDecember 20, 2024
Healthcare Startups to Watch Out for in 2025December 20, 2024
Biobank Blueprint: Redefining Diabetes Diagnosis and Treatment in IndiaDecember 20, 2024
The Future of Malaria Prevention: Can This Vaccine Eliminate the Disease?December 20, 2024